News & Updates

Bronchiectasis preceding AAV onset tied to shorter survival

30 Oct 2020

The association between bronchiectasis and antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) does not appear to be incidental and is mostly correlated with myeloperoxidase (MPO)-ANCA, suggests a recent study.

Bronchiectasis preceding AAV onset tied to shorter survival

30 Oct 2020

Low-dose onabotulinumtoxinA used for TMJ disorders does not affect jaw morphology

30 Oct 2020 by

Low-dose onabotulinumtoxinA (BtxA) does not alter jaw morphology in women receiving BtxA to relieve jaw and facial pain due to temporomandibular joint (TMJ) disorders, a study has shown.

Low-dose onabotulinumtoxinA used for TMJ disorders does not affect jaw morphology

30 Oct 2020

Can antiretroviral therapy slow down DNA time in HIV-1?

30 Oct 2020 by

Initiating antiretroviral therapy (ART) seems to undo age acceleration epigenetic markers in patients with HIV-1, according to a recent study. The effects, however, are partial and are unable to completely reverse the age-associated methylation patterns associated with the infection.

Can antiretroviral therapy slow down DNA time in HIV-1?

30 Oct 2020

Extreme prematurity factors in prolonged hyperglycaemia

30 Oct 2020

Some extremely low-birth weight infants develop hyperglycaemia, which may persist for more than 2 weeks extending to the post-acute phase among those born extremely premature at <24 weeks of gestation, a study has found.

Extreme prematurity factors in prolonged hyperglycaemia

30 Oct 2020

Antipsychotic treatment adherence, cognitive remediation boost brain function in schizophrenia

29 Oct 2020

In the initial period of schizophrenia, consistent adherence to long-acting antipsychotic medication may enhance the effects of cognitive remediation (CR) and produce significant improvements in core cognitive deficits and work/school performance, according to the results of a trial.

Antipsychotic treatment adherence, cognitive remediation boost brain function in schizophrenia

29 Oct 2020

Lopinavir-ritonavir fails to reduce mortality risk in patients hospitalized with COVID-19

29 Oct 2020 by

The antiviral combination of lopinavir and ritonavir does not reduce the risk of death among patients hospitalized with COVID-19, according to results of the UK-based RECOVERY* trial.

Lopinavir-ritonavir fails to reduce mortality risk in patients hospitalized with COVID-19

29 Oct 2020

COVID-19 disrupts breastfeeding plans of new moms

29 Oct 2020

The separation of newborns from their mothers due to control measures for the novel coronavirus disease (COVID-19) pandemic lowers the rate of breastfeeding, both in the hospital and at home, a recent study has found.

COVID-19 disrupts breastfeeding plans of new moms

29 Oct 2020

Frontline nivolumab + chemo ups survival in advanced stomach cancer

29 Oct 2020 by

Adding nivolumab to chemotherapy in the first-line setting significantly improves survival compared with chemotherapy alone in patients with HER2-negative advanced gastric/gastroesophageal (G/GEJ) cancer or oesophageal adenocarcinoma (EAC), shows the CheckMate 649 study presented at ESMO 2020.

Frontline nivolumab + chemo ups survival in advanced stomach cancer

29 Oct 2020

Sitagliptin confers survival benefit in COVID-19 patients with diabetes

29 Oct 2020 by

Initiating COVID-19 patients with type 2 diabetes on sitagliptin at the time of hospitalization appears to reduce mortality and improve clinical outcomes as compared with administering standard-of-care treatment alone, a study has found.

Sitagliptin confers survival benefit in COVID-19 patients with diabetes

29 Oct 2020

Probiotics improve GI symptoms in coeliac disease

29 Oct 2020

Use of probiotics for treating coeliac disease (CD) results in improved gastrointestinal (GI) symptoms, results of a meta-analysis have shown.

Probiotics improve GI symptoms in coeliac disease

29 Oct 2020

News & Updates

Filter by Specialty:

Specialty:

Bronchiectasis preceding AAV onset tied to shorter survival

Bronchiectasis preceding AAV onset tied to shorter survival

Low-dose onabotulinumtoxinA used for TMJ disorders does not affect jaw morphology

Low-dose onabotulinumtoxinA used for TMJ disorders does not affect jaw morphology

Can antiretroviral therapy slow down DNA time in HIV-1?

Can antiretroviral therapy slow down DNA time in HIV-1?

Extreme prematurity factors in prolonged hyperglycaemia

Extreme prematurity factors in prolonged hyperglycaemia

Antipsychotic treatment adherence, cognitive remediation boost brain function in schizophrenia

Antipsychotic treatment adherence, cognitive remediation boost brain function in schizophrenia

Lopinavir-ritonavir fails to reduce mortality risk in patients hospitalized with COVID-19

Lopinavir-ritonavir fails to reduce mortality risk in patients hospitalized with COVID-19

COVID-19 disrupts breastfeeding plans of new moms

COVID-19 disrupts breastfeeding plans of new moms

Frontline nivolumab + chemo ups survival in advanced stomach cancer

Frontline nivolumab + chemo ups survival in advanced stomach cancer

Sitagliptin confers survival benefit in COVID-19 patients with diabetes

Sitagliptin confers survival benefit in COVID-19 patients with diabetes

Probiotics improve GI symptoms in coeliac disease

Probiotics improve GI symptoms in coeliac disease